Proposed changes to protection periods for new treatments garner criticism from industry
The European Parliament’s public health committee has adopted its stance on proposed changes to EU regulations intended to support innovation in medical treatments.
It supports a “comprehensive reform” that will “reward innovation”, the Parliament said, but the pharmaceutical industry has warned that the moves will have the opposite effect.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.